Isolation of hematopoietic stem cells and the effect of CD38 expression during the early erythroid progenitor cell development process

Albeniz,Işıl; Türker-Şener,Leyla; Baş,Aycan; Kalelioğlu,İbrahim; Nurten,Rüstem

doi:10.3892/ol.2011.455

Isolation of hematopoietic stem cells and the effect of CD38 expression during the early erythroid progenitor cell development process

Authors:
- Işıl Albeniz
- Leyla Türker-Şener
- Aycan Baş
- İbrahim Kalelioğlu
- Rüstem Nurten
View Affiliations

Affiliations: Istanbul University, Istanbul Faculty of Medicine, Department of Biophysics, Capa‑Istanbul 34093, Turkey, Department of Obstetrics and Gynecology, Istanbul University, Istanbul Faculty of Medicine, Capa-Istanbul 34093, Turkey
Published online on: October 21, 2011 https://doi.org/10.3892/ol.2011.455
Pages: 55-60

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate changes in primitive hematopoietic cells through CD38 expression, identify the stage at which erythrocyte differentiation CD38 gains activity and the effects of serum factors on this expression by establishing a hematopoietic stem cell system in the erythroid development process. Using an immunomagnetic labeling and separation technique, CD34+ cells were selected from cord blood. The CD34+ cells were cultured in a 2 mM L-glutamine‑enriched medium containing erythropoietin (Epo), penicillin‑streptomycin and stem cell factor (SCF), and were incubated in 5% CO2 at 37˚C. In erythroid development pathways following CD38 expression, primitive/progenitor human hematopoietic cells obtained from cord blood were assessed through the erythroid development process in a serum‑free medium in the presence of proper SCF and Epo. At the end of the 26‑day process, using staining with a Megacult-c staining kit, it was determined that progenitor cells nucleate and differentiate into erythroid cell lines of 8-10 µm. During the course of this process, we analyzed increases over time in NAD glycohydrolase activity rates using the supernatant liquid samples. Results of co-culture experiments in cell culture studies showed that the stimulating effects of CD38 expression originate from specific serum factors. CD38 expression has been shown to occur at hematopoietic cell sources as well as at a number of differentiation levels. In the proliferation process the possible induction of CD38 through specific serum factors leads us to conclude that it may be involved in proliferation with a physiological task or that it may be involved in an event, such as an apoptotic process.

View Figures

View References

1	Verfaillie CM, Pera MF and Lansdorp PM: Stem cells: hype and reality. Hematology. 1:369–391. 2002. View Article : Google Scholar
2	Mitchell KE, Weiss ML, Mitchell BM and Martin P: Matrix cells from Wharton’s jelly from neurons and glia. Stem cells. 21:50–60. 2003.
3	Czyz J, Wiese C, Rolletschek A, Blyszczuk P, Cross M and Wobus AM: Potential of embryonic and adult stem cells in vitro. Biol Chem. 384:1391–1409. 2003. View Article : Google Scholar : PubMed/NCBI
4	Malik P, Fisher TC, Barsky LW, Zeng L, Izadi P, Hiti AL, Weinberg KI, Coates TD, Meiselman HJ and Kohn DB: An in vitro model of human red blood cell production from hematopoietic progenitor cells. Blood. 91:2664–2671. 1998.PubMed/NCBI
5	Bickenbach JR and Stem MM: Plasticity of epidermal stem cell: survival in various environments. Stem Cell Rev. 1:71–77. 2005. View Article : Google Scholar : PubMed/NCBI
6	Sato N, Sanjuan IM, Heke M, Naef F and Brivaniou AH: Molecular signature of human embryonic stem cells and its comporation with the mouse. Dev Biol. 260:404–413. 2003. View Article : Google Scholar : PubMed/NCBI
7	Audet J, Miller CL, Rose-John S, Piret JM and Eaves CJ: Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells. Proc Natl Acad Sci USA. 98:1757–1762. 2001. View Article : Google Scholar : PubMed/NCBI
8	Forsberg EC, Prohaska SS, Katzman S, Heffner GC, Stuart JM and Weissman IL: Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet. 1:281–294. 2005. View Article : Google Scholar
9	Venezia TA, Merchant AA, Ramos CA, Whitehouse NL, Young AS, Shaw CA and Goodell MA: Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol. 2:1640–1651. 2004. View Article : Google Scholar : PubMed/NCBI
10	Steidl U, Kronenwett R, Rohr UP, Fenk R, Kliszewski S, Maercker C, Neubert P, Aivado M, Koch J, Modlich O, et al: Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells. Blood. 99:2037–44. 2002.PubMed/NCBI
11	Wognum WA, Eaves CA and Thomas ET: Identification and isolation of hematopoietic stem cells. Arch Med Res. 34:461–475. 2003. View Article : Google Scholar : PubMed/NCBI
12	Albeniz I, Demir Ö, Türker-Şener L, Yalçıntepe L, Nurten R and Bermek E: Erythrocyte CD38 as a prognostic marker in cancer. Hematology. 12:409–414. 2007. View Article : Google Scholar : PubMed/NCBI
13	Funaro A, Reinis M, Trubiani O, Santi S, Di Primio R and Malavasi F: CD38 functions are regulated through an internalization step. J Immunol. 160:2238–2247. 1998.PubMed/NCBI
14	Mainou-Fowler T, Dignum HM, Proctor SJ and Summerfield GP: The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL). Leuk Lymphoma. 45:455–462. 2004. View Article : Google Scholar : PubMed/NCBI
15	Matrai Z: CD38 as a prognostic marker in CLL. Hematology. 10:39–46. 2005. View Article : Google Scholar : PubMed/NCBI
16	Akel S, Petrow-Sadowski C, Laughlin MJ and Ruscett FW: Neutralization of autocrine transforming growth factor-β in human cord blood CD34⁺CD38⁻Lin⁻ cell promotes stem cell factor-mediated erythropoetin-independent early erythroid progenitor development and reduces terminal differentiation. Stem Cells. 21:557–567. 2003.
17	Kim H, Jacobson EL and Jacobson MK: Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolase. Science. 261:1330–1333. 1993. View Article : Google Scholar : PubMed/NCBI
18	Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
19	Gershoni JM and Palade GE: Protein blotting: Principles and applications. Anal Biochem. 131:1–15. 1983. View Article : Google Scholar : PubMed/NCBI
20	Storms RW, Green PD, Safford KM, Niedzwiecki D, Cogle CR, Colvin OM, Chao NJ, Rice HE and Smith CA: Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood. 106:95–102. 2005. View Article : Google Scholar : PubMed/NCBI
21	Hao QL, Smogorzewska EM, Barsky LW and Crooks GM: In vitro identification of single CD34+CD38− cells with both lymphoid and myeloid potential. Blood. 91:4145–4151. 1998.
22	Neildez-Nguyen TM, Wajcman H, Marden MC, Bensidhoum M, Moncollin V, Giarratana MC, Kobari L, Thierry D and Douay L: Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nature Biotechnology. 20:467–472. 2002. View Article : Google Scholar : PubMed/NCBI
23	Dorn I, Lazar-Karsten P, Boie S, Ribbat J, Hartwig D, Driller B, Kirchner H and Schlenke P: In vitro proliferation and differentiation of human CD34⁺ cells from peripheral blood into mature red blood cells with two different cell culture systems. Transplant Cell Eng. 48:1122–1132. 2008.PubMed/NCBI
24	Jacobson MK, Laurean DC, Strohm MS and Jacobson EL: NAD glycohydrolase and the metabolism of cyclic ADP-ribose. Biochimie. 77:341–344. 1995. View Article : Google Scholar : PubMed/NCBI
25	Zocchi E, Franco L, Guida L, Benatti U, Bargellesi A, Malavasi F, Lee HC and De Flora A: A single protein immunologically identified as CD38 displays NAD⁺ glycohydrolase, ADP-ribosylcyclase and ADP-ribose hydrolase activities at the outer surface of erythrocytes. Biochem Biophys Res Commun. 196:1459–1465. 1993.PubMed/NCBI
26	Albeniz I, Demir Ö, Nurten R and Bermek E: NAD glycohydrolase activities and ADP-ribose uptake in erythrocytes from normal subject and cancer patients. Bioscience Rep. 24:41–53. 2004. View Article : Google Scholar : PubMed/NCBI